Chance will play a decisive factor among proposals that reach certain minimum quality requirements. This is what the United Kingdom and other countries are proposing in upcoming calls for public grants to fund research.
IQS boasts a Triple Quad™ 7500 LC-MS/MS System – QTRAP® device, the triple quad mass spectrometer with the highest sensitivity SCIEX offers, featuring expansive linear range, precision, and instrumental accuracy.
Dr Meritxell Sáez of IQS is conducting a line of research on "Mathematical modelling of embryonic development biology" with the aim of understanding and predicting decision-making at the cellular level.
The six IQS projects that have been awarded grants for the next three years, within the framework of the 2021 "Knowledge Generation Projects" call for grants, have a total budget of nearly €830,000. In addition, two of them were also awarded FPI predoctoral grants.
Dr Georgina Curto defended her doctoral thesis entitled "Artificial Intelligence and Inclusion: An Analysis of Bias Against the Poor," a pioneering work that provides empirical evidence about the existence of aporophobia in Artificial Intelligence systems and social networks.
IQS has participated in the European project PROTEOblood, a cross-border project with the aim of studying and seeking new leukaemia and lymphoma treatments through understanding protein degradation and destruction cycles.
IQS sponsored the inaugural edition of the Biomedical Glycoscience Summer School, organized by the Specialized Carbohydrates Group with the RSEQ in which over 40 researchers in the field of glycosciences participated.
The CTPTI Bioprocess Pilot Plant at IQS has recently carried out various collaborative efforts with companies on projects and developing innovative products in the fields of biostimulants and alternative proteins.
IQS has a RAMAN DRX2 Microscope instrument for material characterization. This technique makes it possible to obtain information on the chemical composition of organic and inorganic compounds in any material condition and even in aqueous solutions.
Dr Bernat Coll defended his doctoral thesis at IQS on 21 February, in which he characterized the SUMOylation of the Rpn5 protein within the context of the proteasome, with an additional study of protein degradation and the potential of chimeric proteins as therapeutic tools.
"My contribution to the ANTIEMT project is designing genetic material transporters. They are invisible polymers for most of the body's cells, except for tumor cells, to which they are targeted as ‘ninjas.’"
In her doctoral thesis conducted at IQS, Dr Noemí Balà has designed a specific device to treat aortic dissection featuring mechanical properties similar to those of the artery, making it possible to improve current treatments.
The representatives from Givaudan Ibérica were able to take a guided tour of the Bioprocess Pilot Plant, led by Dr Planas himself, where they discovered the possibilities offered by this facility first-hand.
IQS is collaborating with the Food and Agriculture Research and Technology Institute’s (IRTA) Fruit Growing – Agroforestry Group and the Government of Catalonia’s Catalan Forestry Agency to develop an analytical method to detect and quantify Deltamethrin. Deltamethrin is an insecticide in the pyrethroid family used to combat pests in stone pine, currently in the trial phase to control Leptoglossus occidentalis.
"Within the University's Research and Innovation Office – which could be defined as a node, a transit station, or a hub for contacts – we can't help in terms of carrying out projects, but we can act as a transit space to connect different groups at our schools."
Within the field of Advanced Materials, IQS has created various spinoffs thanks to the innovative and entrepreneurial spirit of numerous professors and researchers at the university.These initiatives are a clear example of the importance of knowledge transfer from the academic and higher education world to industry.
The R&D&i services and technology transfer offered by IQS Tech Transfer to companies has grown even greater since the end of 2019 through the launch of the Nanotechnology and Advanced Materials Unit located within the Process Transfer and Integrative Technologies Centre (CTPTI) at IQS.
The Nanotechnology and Advanced Materials Unit within the Process Transfer and Integrative Technology Transfer Centre (CTPTI) at IQS boasts several laboratories equipped for research and technology transfer activities mainly related to particle and cell characterization and the analysis and characterization of polymeric materials, biomaterials, ceramic materials, and graphene, among others.
In collaboration with the consulting firm ASYVAL SL, a conference dedicated to the implementation of data integrity has been held at IQS, a policy that ensures that data and records are complete, consistent, secure and accurate, and that they are available throughout their lifecycle.
IQS participates in the European project NEXTGenPS, with the aim of detecting addictive and potentially hallucinogenic substances and facilitating the implementation of control measures for them in the European Union.
Dr. Mireia Castejón recently defended her doctoral thesis at IQS, where she has managed to obtain the tetrasaccharide compound lacto-N-tetraose, present in breast milk, by enzymatic synthesis. This opens the door to obtaining new biocatalysts for the synthesis of HMO oligosaccharides by this route.
"IQS, and throught the ICT+Tourism promoted by ACCIÓ, aims to help transform the tourism sector through new technologies, bringing them closer to companies and providing them with strategic judgement in using them."
IQS is participating alongside other technological and medical research centers in Barcelona on a highly advanced and pioneering project in Europe to produce and use an artificial placenta to ensure survival for extremely premature newborns.
Dr Oller from IQS has recently received a grant from the Semilla programme with the Spanish Cancer Society (AECC) to work on new types of activatable antibodies against a specific marker of resistant cancer cells.
"The Business-University relationship must be very close, each one with its needs and way of working, in a complex but necessary balance within this symbiosis, which in the end, echoes positively throughout society"
The IQS spinoff company, Aortyx, has received €2.5 million euros in "Grant first" funding through the European Innovation Council (EIC) Accelerator Programme. Also, Dr Inés Moreno received one of the prestigious Torres Quevedo Grants at the end of 2021 to conduct her research in this spinoff company.
Researchers from IQS and IDAEA-CSIC collaborate in this project for the analysis of neurotoxic compounds present in water, using advanced methodologies that improve the detection of these compounds and the characterisation of their risk.
Researchers from IQS and IQAC are working together on the development of new synthetic methodologies where they explore the combined use of catalytic systems with the great versatility of chemical elements such as Boron, Iodine and Silicon.
IQS and COMSA Corporación have been working together since 2017 on research, technology and knowledge transfer, a successful collaboration that has so far resulted in five research projects and an industrial doctorate.
Dr. Anna del Pino recently defended her doctoral thesis at IQS, on the optimisation of the manufacturing process of sanitary quality silicone tubes. The research has been carried out within the Industrial Doctorate Plan, in collaboration with the company Venair.
Xavier Aldeguer, General Director of Knowledge Transfer, has conveyed to us the will of the Generalitat de Catalunya to increase the transfer of the university system to the productive system, within the framework of the National Agreement for the Knowledge Society.
The GESPA group at IQS and the URV are working together on the STOP-F-GAS project, where they are studying, within the framework of the circular economy, the development of new technologies for absorbing fluorinated gases for their reuse and obtaining new, more sustainable refrigerant products.
"The HIPRA vaccine project is a big challenge and very exciting. I had never been in a project with such a degree of involvement, and with that scope. We live it with a lot of heart and with a lot of emotion "
Under the title “From an idea to the market,” the aim has been to visualize the technology transfer process from the outset when someone comes up with an idea and wants to protect it up to the signing of a license agreement with a third party
IQS and the company Hausmann have collaborated in the development of an innovative system for the elimination of olfactory contamination in the process of water used in the manufacture of flavourings, based on its capture using graphene oxide.
Within the Collaboration Challenges program, Aortyx and the GEMAT group collaborate in the development and preclinical validation of a new endovascular medical device with localized and controlled release of anti-progression drugs for aneurysms.
The SEAT-IQS Applied Mechanics Laboratory has recently acquired a new Olympus DSX1000 digital microscope, the latest addition to the various advanced inspection and non-destructive analysis equipment that the laboratory features.
Both scientific dissemination and dissemination are communication activities. Scientific articles are the essential way to disseminate the results of a project to the scientific community, while dissemination actions are aimed at a more general public to make scientific knowledge more accessible to citizens.
The Lafora disease patients association "Chelsea's Hope Lafora Children Research Fund" has just granted Dr Jordi Duran, Professor of Bioengineering at IQS, new funding for his research on this rare neurodegenerative disease.
IQS (Ramon Llull University) and PerkinElmer have recently signed a partnership agreement to offer a new Industrial Doctorate (ID) as part of the Government of Catalonia's Industrial Doctorate Plan , co-financed between the company and the university.
Dr Núria Puigmal defended her doctoral thesis at IQS, where she has developed new dermal microneedles for immunotherapies, which can perform the dual function of drug release platform and treatment monitoring.
"Within the framework of the Next Generation Recovery Plan, collaboration between Academia and Business is essential, from centres such as IQS, to promote Technological Cooperation, to work together to promote the change that this country needs and to make a clear commitment to the future".
Alongside several researchers and professors from the IQS School of Engineering, IQS has once again taken part in the events and seminars held as part of the Expoquimia 2021 event to showcase the essential role of the university in technology innovation and transfer in Spain.
Shimadzu has given IQS, through Izasa Scientific, the TQ-8050NX equipment, a triple quadrupole GCMS with advanced specifications that is used for the evaluation in the analysis of dioxins and the development of related specific methodologies.
Dr Elena de las Heras recently defended her doctoral thesis at IQS, in which she has designed and developed new photo-immuno-chemo-nanotransporters, which have shown high photodynamic activity against tumour cells and are effective and safe for the photodynamic delivery of doxorubicin on demand.
Dr Cristina García has recently defended her doctoral thesis at IQS, in which she has developed a urinary catheter equipped with a micro-and nano-structured coating with bacteriophobic characteristics, offering a clear alternative to commercial catheters.
Within the Industries of the Future community, IQS has participated in the PLASTFUN project where advanced surface functionalities and their large-scale production have been defined, and now has a validated simulation tool for optimising parameters under industrial conditions.
IQS and the company Xenopat recently signed a collaboration agreement to carry out joint research projects concerning cancer and offer services to third parties by combining both entities' experience, including ADME-Tox, computational prediction, and in vivo efficacy studies, among other pharmacokinetic studies.
El Dr. Pol Cabanach ha defendido recientemente su tesis doctoral en IQS, en la que desarrolla dos tecnologías basadas en materiales zwitteriónicos: un sistema oral de liberación de fármacos para el tratamiento de la malaria y una fotorresistencia para la microimpresión de micro-robots no-inmunogénicos.
El Dr. Germán Febas defendió recientemente su tesis doctoral realizada en el grupo GEMAT de IQS, donde ha desarrollado y patentado un dispositivo médico que sella el orificio realizado en la membrana corioamniótica después de una fetoscopia, con el objetivo final de reducir el riesgo de rotura de esta membrana y salvar la vida del futuro bebé.
El profesor de IQS, el Dr. Octasiano Valerio Mendoza lidera el proyecto Chinequaljustice, que tiene el objetivo de estudiar las desigualdades económicas y sociales en China, desde un modelo económico novedoso basado en la teoría Capability Approach, entendiendo el bienestar en términos de las capacidades y del funcionamiento de las personas.
IQS Tech Transfer y la empresa Vision Arcanum colaboran en un proyecto para el reconocimiento digital de estructuras químicas dibujadas a mano, en pantalla táctil o en papel, utilizando modernas técnicas de visión por ordenador (Modern Computer Vision Techniques) basadas en Machine Learning.
IQS firmly believes that patents are of vital importance and that they allow us to position ourselves in certain industrial environments. They add value to what we do and are a way of transferring the results of our scientific activity to society. For this reason, we aim for every patent application to be accompanied by a strategy for its commercialization via a license to a company or a spinoff that makes its industrial application viable.
“I am a scientist at heart, that science is very important, and that it only translates into a benefit for society when it is conducted with ethical values such as rigour, transparency, and integrity. These values were instilled in me during my education at IQS”.
IQS dispone de un nuevo equipo de ultra gama, SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP®, instalado en el recientemente creado IQS-SCIEX Demo Lab, que permitirá ampliar las posibilidades de investigación avanzada y la oferta de transferencia de tecnología a la industria.
Researchers from IQS have been part of the REGiREU project, in which the objective is to replace the current management of the water cycle with a model in accordance with the principles of Circular Economy, leading the study to replace mercury lamps with UV- LEDs.
Researchers from IQS are part of the NeuroTICs project, a consortium created to establish a new generation of therapeutic agents against poisoning by neurotoxic agents, as well as to determine their action, using zebrafish and rodent models for the study.
On 10 May 1991, the proposal to create Ramon Llull University was unanimously approved by the Parliament of Catalonia, under Law 12/1991, published in the Official Gazette of the Government of Catalonia (DOGC).
Researchers from IQS have participated in the TRANSPORT project, leading the development and optimization activities of "lattice" type structures to achieve lighter parts through 3D printing, thus providing knowledge and experience in the field of additive manufacturing.
Within the framework of the QuirofAM project, the CIM center, the IQS GEMAT group and the Tractivus spin-off, have co-developed a 3D printer that allows printing of medical grade silicone for the manufacture of medical devices. As a first demonstrator, the researchers have developed a completely customized tracheal stent.
The Biochemistry Laboratory at IQS has analysis techniques to verify if the protein hydrolysates comply with European standards which limits the presence of proteins with a molecular weight over 10kDa.
“Formar parte del Patronato de la Fundación IQS es para mí una oportunidad de intercambio de conocimientos, de aprendizaje y, por qué no, de perseguir el sueño de que IQS sea el referente de sostenibilidad, en el sentido más amplio, dentro de UNIJES”.
The offer of R&D&i services that IQS Tech Transfer provides companies has been expanded since 2020 with the launch of the Continuous Chemical Processes Unit, installed in the CTPTI at IQS, which is aimed at improving fine chemistry processes to make them safer, faster, and cleaner.
With Process Analytical Technology (PAT), it is possible to monitor the reactions that take place in the Flow Chem Unit reactors. Moreover, any substance or mixture can be characterized with the equipment in the Thermal Analysis Laboratory (DSC and TGA).
The facilities and equipment at the CTPTI Continuous Chemical Processes Unit make it possible to apply new advanced manufacturing technologies in fine chemicals, which opens up the possibility of comprehensively developing safer, faster, and cleaner chemical processes.
"Collaboration between companies and research centres is beneficial for both parties, because it's a source of technological ideas and possibilities and because it provides knowledge about what the market is looking for and what it needs."
Through the publication and dissemination of this special issue dedicated to the Continuous Chemical Processes Unit, we would like to present the facility, the equipment and instruments that comprise it, the various services that we can offer to industry, and the excellent personnel without whom the project would not be a reality.
La tesis doctoral defendida recientemente por el Dr. Mario López está centrada en terapias duales para el tratamiento de enfermedades cardiovasculares y antimicrobianas, basadas en la administración de óxido nítrico, introducido en vectores poliméricos de pBAE.
“We want that when a student joins the IQS family, they feel that they're supported by IQS for their entire life, even beyond their period as a student, IQS will be by their side throughout their professional life. IQS offers all the elements to provide COMPREHENSIVE value to our stakeholders, and we must take advantage of all this to the fullest. ”
IQS has a Leica SP8 Confocal Scanning Microscope used for any application that involves the analysis of images that emit fluorescence, on their own or if they have been previously labeled with fluorophores, that allows the analysis of materials and biomaterials in addition to the analysis of biological tissues and cell culture.
IQS researchers of the Endovascular Repair Patch project, carried out within the AGAUR 'Product' call, have achieved both the definitive design of the deployer and the biocompatible materials that allow the administration of a patch for the repair of arteries affected by aortic dissection .
To everyone who contributes to IQS through donations, sponsorships, or patronage, we thank you all. We will never tire of acknowledging your commitment to IQS. We know that you are here with us and that we can count on you.
In her doctoral thesis carried out at IQS School of Management, Dr. Nour Chams shows the impact of the human factor and financial indicators on sustainability performance in a group of companies with an international perspective.
In her doctoral thesis carried out in the Department of Bioengineering of IQS, Dr Núria Orive designed different metabolic engineering strategies to increase the production of glycoglycerolipids, interesting products due to their potential use as vaccine adjuvants or tumor suppressors.
In July 2018, public health authorities became aware of the presence of the N-nitrosodimethylamine (NDMA) impurity in Valsartan batches for the first time. In the following months, other nitrosamines in drugs were detected from the same family (sartans), such as Ibersartan or Losartan, and in other drugs such as pioglitazone, ranitidine, and metformin.
In 2005, the European Commission adopted a European Charter for Researchers and a Code of Conduct for the Recruitment of Researchers with the aim of making research careers in Europe more attractive. It also promoted the HRS4R (Human Resources Strategy for Research) strategy to support universities, research institutions, and organisations that fund research with the ultimate goal of contributing to the development of an attractive European labour market for researchers.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.